The government of Mexico on Thursday rescinded its ban on U.S. biotech (GE, or genetically engineered) corn. “Mexico’s action ...

Years of a back-and-forth battle over Mexico’s plan to ban imports of corn grown with biotech and glyphosate is finally, ...

BOSTON—Barbara Weber, the Chief Executive Officer of Tango Therapeutics, Inc. (NASDAQ:TNGX), a $350 million market cap biotech company, recently sold a portion of her holdings in the company.

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has updated employment agreements with key executive officers, including ...

BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...

An immigrant entrepreneur, Andrea Pais cofounded Novel Microdevices by figuring it out as she went along — and learning where to find support.

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

“Farm Bureau applauds Mexico’s President Claudia Sheinbaum for repealing her country’s ban on biotech corn imports from ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Shanghai Henlius Biotech, Inc. (“Henlius”) announced FDA acceptance of the Biologics License Application (BLA) for ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.